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ABSTRACT: The principles of β-sheet folding and design for
α-peptidic sequences are well established, while those for sheet
mimetics containing homologated amino acid building blocks
are still under investigation. To reveal the structure−function
relations of β-amino-acid-containing foldamers, we followed a
top-down approach to study a series of α/β-peptidic analogs of
anginex, a β-sheet-forming antiangiogenic peptide. Eight
anginex analogs were developed by systematic α → β3
substitutions and analyzed by using NMR and CD spectroscopy. The foldamers retained the β-sheet tendency, though with
a decreased folding propensity. β-Sheet formation could be induced by a micellar environment, similarly to that of the parent
peptide. The destructuring effect was higher when the α → β3 exchange was located in the β-sheet core. Analysis of the β-sheet
stability versus substitution pattern and the local conformational bias of the bulky β3V and β3I residues revealed that a mismatch
between the H-bonding preferences of the α- and β-residues played a minor role in the structure-breaking effect. Temperature-
dependent CD and NMR measurements showed that the hydrophobic stabilization was scaled-down for the α/β-peptides.
Analysis of the biological activity of the foldamer peptides showed that four anginex derivatives dose-dependently inhibited the
proliferation of a mouse endothelial cell line. The α → β3 substitution strategy applied in this work can be a useful approach to
the construction of bioactive β-sheet mimetics with a reduced aggregation tendency and improved pharmacokinetic properties.
■ INTRODUCTION
The design of water-soluble β-sheet models mimicking
structural and functional features of proteins is an enduring
challenge. The underlying principles of β-sheet folding and
design for natural α-peptidic sequences have been thoroughly
studied.1−7 De novo designed structures have been reported to
form β-hairpins,8,9 three-stranded β-sheets10−16 and β-sand-
wiches.17−19 Hairpins proved to be useful protein epitope
mimetics with bioactive potencies.20
Foldameric sequences with unnatural building blocks in the
chain are an important class of β-sheet mimetics. In a bottom-
up approach, it has been shown that homologated amino acids
can be utilized to build short turns21−25 and cyclic α/β-peptides
as hairpin models.26 Nonpeptidic template and turn units have
been combined with peptides to construct parallel and
antiparallel sheet structures, some of them having intriguing
bioactivity.27,28 Sheet-like self-organization has been found for
α/β-peptides at the air/water interface29 and in fibrillous β-
peptidic nanostructures.30−34
The top-down approach starting from α-peptidic β-hairpins
has revealed complex behavior when the β-amino acid
substitutions are made in the hydrophobic core. In matching
positions of the two strands, the α→ β3 modification results in
a changed H-bond pattern and an altered side-chain display as
compared with the natural β-sheet structure,35 which leads to
decreased structural stability. The alternative design strategies
maintaining the native side-chain orientation substitute two α-
amino acid residues by a single β-amino acid (αα → β2 or β3),
or applies special β2,3-residues.36 These substitution strategies
have been tested for 16-residue disulfide-cyclized β-hairpin
peptides with a hydrophobic cluster of four amino acids. The
focus has been placed on the structural stability, but these
sequence changes may lead to the loss of key side-chains in a
biologically active β-sheet. A 19mer hydrophobic sequence with
β-amino acid substitutions was recently shown to form a three-
stranded sheet structure in organic solvents.37
Whereas the top-down approach to construct bioactive
foldameric helices has become successful,38 the rules of possible
β-amino acid replacements in a multiple-stranded water-soluble
bioactive β-sheet still remain to be investigated. It is not known
whether the core α → β mutations in a hydrophobically
stabilized system cause the same alterations as in the hairpin
models. Whether an α → β substituted β-sheet region can
retain its biological activity is a particularly important question.
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Our aim was a systematic probing of the effects of β3-amino
acid substitutions in a water-soluble, biologically active β-sheet-
forming peptide. The 33mer peptide anginex, a designed β-
sheet-forming peptide with antiangiogenic and antitumor
activities,39−43 was chosen as model system. Anginex forms a
β-sandwich structure via association to dimers and tetramers at
higher concentrations,10,44 and upon interaction with n-
dodecylphosphocholine (DPC) micelles.45 In the concentration
range of in vitro studies, its prevailing conformation is random
coil,10,46 but the three-stranded β-sheet-forming propensity is
crucial for the antiangiogenic activity.46 We hypothesize that
the effects of the core α→ β substitutions can be well detected
in this relatively sensitive system, and the corresponding
biological properties may be good indicators of the structural
changes. We demonstrate here that the analogs with α → β3
substitutions in particular positions retain the inducible β-sheet-
folding propensity of anginex. More importantly, they also
exhibit biological activity compared to the maternal molecule
indicating a close structure−function relationship.
■ RESULTS
Backbone Substitution Strategy. The majority of
residues in the sheet-forming region of anginex are crucial for
bioactivity in in vitro tests.47,48 These involve the side-chains
responsible for the hydrophobic stabilization of the structure
and interaction anchor points over the surface of anginex. To
retain the side-chain chemistry, β3-amino acids were chosen for
the α → β substitutions. Avoiding sheet stabilization strategies
with amino acid deletion36 allowed us to monitor the structural
adaptation of the system without losing bioactivity due to
missing potential pharmacophore points. The β3-residues may
alter the peptide bond and side-chain orientations, and
replacements in matching positions are therefore expected to
minimize the destructuring effects. Triplets of α-residues in
matching positions were replaced along the three-stranded β-
sheet (Figure 1). Six sequences (1−6) were designed with the
in-registry substitution pattern covering the sheet-forming
region over the distance of six residues. The length of the
sheet segment enabled us to analyze the effects of the distance
from the turn regions. Two additional sequences were
constructed with nonmatching backbone homologations to
test the hypothesis of matching replacements in this system: a
diagonal (7), and a sequential pattern (8). These sequences
allowed the investigation of several triplet substitutions,
including various types of amino acids, as regards hydro-
phobicity, charge, side-chain volume and branching.
Overall Folding Propensity. As stated above, the β-sheet
of anginex is highly sensitive to the conditions. NMR structure
elucidation studies have revealed that a micelle-forming
detergent, n-dodecylphosphocholine (DPC), induces its
folding.45 The CD analysis was therefore carried out in K-
phosphate buffer at pH 5.6 with and without 2.5 mM DPC.
The concentration of DPC was chosen to keep the background
absorbance low, but above its critical micelle concentra-
tion,49−51 to ensure micelle formation.
In buffer only, the CD curve of anginex with a minimum at
around 217 nm proved the β-sheet structure of the 33mer
(Figure 2A). The CD traces of the analogs shared a common
minimum at around 200 nm, with variable intensity, and
suggested partial folding. Small differences were observed in the
shoulders near 217 nm, which were earlier used as indicator of
β-sheet content for anginex-related β-sheet peptides.4 Ex-
pressed relative to the CD intensity of anginex at 217 nm, the
analogs displayed β-sheet contents in the range 25−42%
(Figure 2A, inset), which indicated their reduced folding
propensities. Peptides 6 and 1, substituted at the edges of the β-
sheet, exhibited the highest intensities.
The structuring effect of DPC on the analogs was clearly
apparent in the CD curves (Figure 2B). The increased β-sheet
content of anginex upon the addition of DPC was transparent
only in the NMR spectra, whereas the CD profile displayed
only minor changes. For 1−8, the minima shifted toward 210
nm, with a zero cross-point around 200 nm, and the intensity of
the shoulders near 217 nm increased. DPC not only induced
the formation of the β-sheet, but also enhanced the differences
between the folding propensities of the analogs (Figure 2B,
inset). The relative β-sheet content was in the range 61−98%,
which suggested that an interacting partner can induce β-sheet
formation. The destructuring effect of the β3-amino acid
insertions was position-dependent. The closer the α → β3
substitution was to the β-sheet core, the lower was the folding
propensity. Sequences 7 and 8 did not show a significant
difference from the in-registry mutated analogs (1−6),
Figure 1. The three-stranded β-sheet alignment of anginex
represented in one-letter code amino acid sequence, with the
substitution patterns: in-registry (1−6), diagonal (7) and sequential
(8) indicated with dotted lines. The yellow background indicates the
sheet-forming regions of anginex. Side chains of β3-amino acids are
indicated by the standard α-amino acid one-letter codes.
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indicating that there was no extra sheet-breaking effect due to
the nonmatching local conformational behavior of the β- and
the surrounding α-residues.
Conformation at the Residue-Level. Chemical shift
analysis52,53 was used to gain a deeper insight into the β-
sheet-forming propensity at the amino acid level. In the absence
of DPC, heteronuclear NMR spectra were measured and
assigned for the peptides in natural abundance under optimized
concentration,10 temperature and pH (Figure S1). All the
identified NH, Hα, Cα and Cβ resonances (Table S1) were
included in the analysis. The secondary structure propensity
(SSP) score54 was calculated by using the ssp software.
Resonances of the β3-residues and glycines were excluded from
the calculation, because of the lack of reference values and their
poor β-sheet indicator property,54 respectively. Although the
secondary structure-independent neighborhood effect of the β3-
residues on the magnetic environment of the adjacent α-
residues can not be ruled out, we did not observe any major
systematic influence on the secondary chemical shifts, such as
outlier values around the α → β3 substitutions.
The SSP scores of anginex (Figures 3 and S2) in the second
(K19−L24) and third (R28−D33) sheet segments were in the
range −0.18 to −0.40, demonstrating the presence of the β-
sheet conformation. The N-terminal part (V7−F12), however,
exhibited SSP values corresponding to a random coil structure.
This was in line with the earlier structural data for anginex,
showing that the first strand of the β-sheet was more flexible
than the other two.45 Similar folding patterns were observed for
the α/β-analogs, but the overall sheet-forming tendencies of the
second and third strands were lower than found for the parent
anginex. The β3-residues in the first strand induced low helical
propensities, which was in line with the helix-promoting nature
of these building blocks. The β-sheet content followed a similar
trend as observed in CD experiments. Analogs with α → β3
mutations at the periphery of the β-sheet (1 and 6) displayed
the highest overall β-sheet content. Substitutions in the core
region shifted the SSP scores closer to the random coil values.
On addition of the structure-inducing DPC to the NMR
samples, signal broadening was observed, which did not allow
signal assignment and high-resolution structure analysis. We
suppose that the origin of the resonance broadening was an
intermediate time-scale chemical exchange between the β-sheet
and the disordered populations.4 Nevertheless, downfield-
shifted signals of anginex appeared at around 5−6 and 8.5−
9.5 ppm for the Hα and NH resonances, respectively (Figures
S3 and S4), which indicated a predominant β-sheet. For the α/
β-analogs, the most pronounced resonance broadening was
observed for 1 and 6 (Figure S4). For 1, signals of Hα protons
could also be identified at around 5−5.5 ppm, and the
Figure 2. CD curves of anginex (anx) and its α/β-analogs at 100 μM
and pH 5.6 without (A) and with (B) 2.5 mM DPC. Anginex/analog
intensity ratios at 217 nm are displayed (inset).
Figure 3. Envelopes of the SSP scores of anginex and its α/β-analogs,
derived from the chemical shifts measured in HEPES pH 5.6 at 500
μM. For simplicity, the values next to the omitted residues are
connected and the detailed results for the individual SSP scores for
each residue are presented in Figure S2. The different NMR
resonances for a given residue were combined into a single score
between 1 and −1, providing a quantitative estimate of the fractional
secondary structure. Positive and negative scores corresponded to helix
and sheet structures, respectively. Because of the partial assignment,
the N-terminal A1, N2 and the loop residue H15 were not included in
the analysis.
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corresponding Hα−Hα NOE peaks were also detected,
demonstrating the increased β-sheet content (Figure S5).
The local conformational flexibility of the β3-residues could
be indicated by the chemical shift difference (Δδ) observed for
the diastereotopic Hα protons. We found nonuniform behavior
for the Δδ values in the β-amino acids (Table S2). For the β3V-
and β3I-residues, the Δδ values were in the range 0.14−0.24
ppm, i.e., systematically higher than the average Δδ (0.11 ppm),
indicating increased local rigidity. It has been reported that
side-chain branching adjacent to the β-carbon atom stabilizes
the H14-helix,55 which is possible only if there is a propensity
to attainment of a gauche θ torsion. To test whether the
increased rigidity was a result of a gauche conformational bias,
we analyzed the 3J(Hα−Hβ) couplings and the Hα−NH NOE
intensity patterns around the β3V- and β3I-residues.
Large 3J(Hα1−Hβ) (>10 Hz) values were uniformly
accompanied by elevated INOE(Hα1−NH)/INOE(Hα2−NH)
ratios, indicating a conformational bias toward the local
conformation C (Figure 4). The gauche conformation C was
compatible with the geometrical requirements of a β-sheet in
terms of accommodation to the H-bonding network. On the
other hand, the side-chain orientation and the overall backbone
curvature supported the hypothesis that these homologated
residues did not properly fit into the closely packed
hydrophobic cluster of surrounding α-residues.
Effects on the Hydrophobic Forces and Self-Associa-
tion. Hydrophobically driven oligomerization of anginex at
elevated concentrations plays important roles in the stabiliza-
tion of the β-sheet.44 In order to test the presence of this
phenomenon for the α/β-derivatives, pulsed field-gradient spin
echo (PFGSE) Diffusion Ordered Spectroscopy (DOSY) NMR
measurements were carried out. With an apparent hydro-
dynamic radius of 15.6 Å, the positive control anginex formed
tetramers at the concentration of 500 μM at 37 °C (Table 1).
This finding was in good agreement with the literature data.10,44
From CD and independent NMR data, increased disorder was
observed for the foldameric analogs, which has a radius
increasing effect for a single chain without oligomerization.56
The analogs (1−8) exhibited apparent hydrodynamic radii in
the range 14.0−14.9 Å indicating a small decrease relative to
anginex. This can be explained by a diminished tendency to
self-association for α/β-derivatives, which counteracts the
increased dimensions of the partially unfolded chains.
Besides the aggregation phenomena, hydrophobic forces also
facilitate the intrachain clustering of the hydrophobic side
chains, thereby stabilizing the β-sheet fold. The hydrophobic
stabilization effect scales up with temperature,57 which allows
testing of the presence and the weight of these interactions.
Temperature-dependent CD curves were analyzed, and higher
CD intensities (at 217 nm) were observed for anginex and its
analogs (1−8) at elevated temperatures (Figures 5 and S6). For
anginex, the maximum CD intensity was at around 55 °C, and
the ellipticity decreased at higher temperatures (structural
melt). The analogs exhibited a monotonous enhancement in β-
sheet content from 5 to 75 °C, though with lower overall
negative slopes, pointing to a lower hydrophobic contribution.
Further, the negative temperature gradient was highest for
Figure 4. Schematic representation of the three local minima around
the θ torsion of the β3-residues: gauche − (A), antiperiplanar (B), and
gauche + (C). The combination of 3J(Hα1−-Hβ) >10 Hz and
INOE(Hα1−NH)/INOE(Hα2−NH) > 1.5 indicates a bias toward
conformation C. Modeled local geometry of β3V22 (yellow backbone)
within the β-sheet, and its comparison with the parent structure (blue
backbone) (D). The modeling protocol is given in the Supporting
Information text.
Table 1. Estimated Diffusion Coefficients (D) and Apparent
Hydrodynamic Radii (r) Derived from DOSY NMR
Measurements
D r
(10−10 m2s−1) (Å)
anx 2.11 15.6
1 2.20 14.9
2 2.25 14.6
3 2.27 14.5
4 2.23 14.8
5 2.27 14.5
6 2.35 14.0
7 2.25 14.6
8 2.29 14.4
Figure 5. Mean residue ellipticity values at 217 nm versus temperature
in the range 5−75 °C.
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sequences with α → β3 mutations located distant from the
hydrophobic core of the β-sheet (1 and 6). In line with the CD
findings, the Hα chemical shifts of anginex displayed downfield
shifts in response to increasing temperature58 (Figure S7),
indicating that the higher CD intensities at 217 nm reflected
more stable β-sheets.4 For 1 and 6, the Hα downfield shifts
could be observed, but overall, the α/β-derivatives exhibited
decreased or missing temperature-dependent response.
These CD and NMR findings strongly suggested that the
hydrophobic interactions are scaled down in the α/β-analogs
relative to anginex, and this supported that the structure-
breaking effects of the β3-residues were also exerted through
disruption of the hydrophobic packing and self-association.
Inhibition of Proliferation of Endothelial Cells. The
DPC-induced β-sheets of the α/β analogs held promise for
retained bioactivity. Anginex has been shown to exert in vitro
antiproliferative effects in several vascular endothelial cell
lines.39,41,47,59 In our experiments, bEND.3, a mouse brain
microvascular endothelial cell line previously shown to be more
sensitive to anginex treatment than other murine cell lines,41
was used to test the biological effects. Anginex displayed an
IC50 value of 21.8 μM. The α/β analogs 2, 3, and 6 displayed
significant dose-dependent inhibition with IC50 values of 29.8,
44.2, and 29.7 μM, respectively (Figure 6). The antiproliferative
activities of sequences 2 and 6 were comparable with that of the
parent anginex. These results suggested that the inducible β-
sheet was sufficient for the retention of this particular
bioactivity. Analogs 1, 4, 5, 7, and 8 showed no significant
inhibitory effect. We note that enhancements of the endothel
proliferation at low concentrations compared to the control
were observed for 5, 7, and 8, but this effect did not show
concentration-dependence. Similar enhancements have been
found for anginex-related sequences in the literature.47 Key
residues of anginex were previously identified in sequence-
activity relationship studies, including Ala-scan.39,48 Our
substitution strategy affected some of these key residues: Val7
and Leu24 in 1, Val22 in 3, Leu11 and Ile20 in 5. The
bioactivity of peptide 3 strongly supported that these side-
chains were properly oriented in the α/β-peptide analog. In
contrast, peptide 1 did not display an antiproliferative effect in
spite of its relatively high folding propensity. This could be
explained by the substitution of two key residues in this
peptide, which could result in a geometrically unfavorable side-
chain presentation over the molecular surface and incompat-
ibility with the pharmacophore pattern.
■ CONCLUSIONS
Through a systematic α → β3 substitution approach, eight
foldameric analogs of anginex were synthetized with β3-amino
acid building blocks in the β-sheet region. The mutated
sequences display decreased folding propensities,35,36 whereas
an interacting partner (DPC) can induce β-sheet formation in a
very similar way to that of the parent anginex. The reduction in
β-sheet content is dependent on the position of the β3-residues
relative to the β-sheet core: α → β3 substitutions in the core
region give rise to a greater destructuring effect than those at
the edge. Analyses of the effects of the substitution patterns and
the local geometry of the β3-residues with branching next to the
Cβ (β3V and β3I) suggest that the destructuring effect is not
primarily due to the potentially impaired H-bonding network
around the β3 building blocks. The temperature-dependent
measurements have revealed that the hydrophobic driving
forces are scaled down in the α/β-peptidic analogs. This can be
explained by the backbone curvature and the angled side-chain
of the β3-residues relative to the best plane of the β-sheet,
which are possibly not fully compatible with the packing
requirements of the hydrophobic interactions. Structure−
function analysis demonstrates that, inducibility of the
appropiate secondary structure of the foldameric α/β-peptidic
anginex analogs is sufficient to diminish endothelial cell
proliferation. Although α → β3 replacements can also be better
tolerated than Ala mutations,60 certain α → β3 substitutions
may also affect the geometry of the side-chain display, which
could break down the bioactivity. The design of an α/β-
peptidic β-sheet mimetic with the proposed approach can result
in biologically useful materials. Moreover, the general tendency
to uncontrolled aggregation of the β-sheet proteins can be
tamed with this approach, and the insertion of the homologated
residues improves the enzyme resistance and thereby the
pharmacokinetic properties.
■ EXPERIMENTAL SECTION
Peptide Synthesis and Purification. The synthesis of the
sequences with microwave irradiation led to byproducts: aspartimide
formation between D26-G27 and epimerization of D33. The
byproducts were eliminated by using Fmoc-Asp(OtBu)-Gly(DMb)-
OH (Novabiochem) for D26-G27 coupling. Tentagel R RAM resin
was used as solid support and HATU as coupling reagent. Couplings
were performed in a 3-equiv amino acid excess at 75 °C for 15 min for
α-amino acids, and for 30 min for β3-residues. Histidine was coupled at
50 °C; arginines were coupled in two cycles. Peptides were cleaved
with TFA/water/D,L-dithiothreitol/triisopropylsilane (90:5:2.5:2.5),
then precipitated in ice-cold diethylether. The resin was washed with
acetic acid and water, then filtered, and lyophilized. Peptides were
Figure 6. Effects of anginex and its α/β-analogs on the proliferation of the bEND.3 mouse microvascular endothelial cell line. Cells were pretreated
with or without the peptides for 1 h, and then, after washing, further cultured for 3 days. Proliferation was measured by using XTT test, and the
values are given as percentages of the cell proliferation in the absence of peptides.
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purified with RP-HPLC on a C18 column (Phenomenex Jupiter, 4.6 ×
250 mm). HPLC eluents were the following: (A) 0.1% TFA in water
and (B) 0.1% TFA, 80% ACN in water, with a gradient from 30% to
60% B in 60 min, at a flow rate of 4 mL min−1. Purity was confirmed
by analytical RP-HPLC and ESI MS measurements.
Circular Dichroism Measurements. Circular dichroism measure-
ments were performed with a Jasco J-815 CD-Spectrometer. CD
spectra were recorded by using a 1 mm thermally jacketed quartz
cuvette, from 260 to 190 nm, at a scan speed of 100 nm min−1 with 8
accumulations. The peptide concentration was 100 μM in pH 5.6 K-
phosphate buffer with or without 2.5 mM DPC. For thermal control, a
Julabo water thermostat was used with a 10 min equilibration time for
each temperature. Solvent baseline was subtracted.
NMR Experiments. NMR spectra were recorded on a Bruker
Avance III 600 MHz spectrometer equipped with a 5 mm CP-TCI
triple-resonance cryoprobe. Compounds were dissolved at a
concentration of 0.5 mM in 20 mM, pH 5.6 d18-HEPES buffer (90%
H2O, 10% D2O) containing 0.02% NaN3. For referencing, 4,4-
dimethyl-4-silapentane-1-sulfonic acid (DSS) was used as an external
standard. For resonance assignment, 2D homonuclear TOCSY and
NOESY, and 2D heteronuclear 15N and 13C HSQC experiments were
performed. The NOESY mixing time was 225 ms and the number of
scans was 32. TOCSY measurements were made with homonuclear
Hartman−Hahn transfer, using the DIPSI2 sequence for mixing, with
a mixing time of 80 ms; the number of scans was 32. For all the 2D
homonuclear spectra, 2K time domain points and 512 increments were
applied. 13C HSQC experiments were performed under the same
sample conditions, but the buffer was prepared in D2O. Signal
assignment was based on the 2D NMR spectra obtained at 37 °C. 1D
1H NMR spectra of the 0.5 mM samples were also measured in pH 5.6
K-phosphate buffer at 37 °C, with or without 2.5 mM d18-DPC. All
1H
spectra were acquired with the excitation sculpting solvent suppression
pulse scheme.61 Processing was carried out by using Topspin 3.1
(Bruker), a cosine-bell window function, single-zero filling, and
automatic baseline correction. Spectra were analyzed by Sparky 3.114
(T. D. Goddard and D. G. Kneller, University of California, San
Francisco).
The secondary structure propensity (SSP)54 score was calculated by
using the ssp software. The refDB random coil reference set based on
the chemical shifts of properly referenced known protein structures62
was used.
Pulsed Field-Gradient Spin Echo (PFGSE) NMR Measure-
ments. PFGSE NMR measurements were performed at 37 °C by
using the stimulated echo and longitudinal eddy current delay (LED)
pulse sequence with excitation sculpting for water suppression.63 A
time of 3 ms was used for the dephasing/refocusing gradient pulse
length, and 300 ms for the diffusion delay. The gradient strength was
changed quadratically (from 5% to 80% of the maximum value); the
number of steps was 32. Each measurement was run with 64 scans and
8K time domain points. DOSY spectra were processed and evaluated
by using the exponential fit implemented in Topspin 3.1. For
processing, exponential window function and single zero filling were
applied. The aggregation numbers were calculated from the Stokes−
Einstein equation and trimethylsilyl propanoic acid (TSP) was utilized
as an external volume standard.
Endothelial Proliferation Assay. Murine brain endothelial cell
line bEND.3 was cultured in DMEM containing 10% fetal calf serum.
The endothelial cells (900 cells/well) were plated onto a 96-well tissue
culture plate and incubated for 1 h in the presence or absence of
different concentrations (5, 10, 25, and 50 μM) of anginex or anginex
analogs (dissolved in DMSO and diluted in 10 mM HEPES pH 7.4
containing 150 mM NaCl). The incubation time of 1 h was selected to
eliminate uncontrolled peptide aggregation in the cell culture medium
leading to nonspecific effects. Cells in control samples were treated
with an equivalent amount of the solvent (DMSO and HEPES-NaCl).
After incubation for 1 h, bEND.3 cells were washed twice with
HEPES-NaCl, and then cultured further for 3 days. The proliferation
of bEND.3 was measured by XTT assay64 according to the
manufacturer’s instruction (Sigma-Aldrich). For the last 2 h, XTT
was added to the samples and the resulting absorbance was measured
with a Microplate Reader (Multiskan, Thermo Electron Corporation)
at 450 nm. The experiments were repeated three times in triplicate.
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